This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Mats Nagard - Innovator in Pharmaceutical Compounds
Introduction
Mats Nagard is a notable inventor based in Molndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on novel compounds.
Latest Patents
Mats holds 1 patent for his invention titled "MGluR5 modulators." This patent is directed towards novel compounds, detailing a process for their preparation, their therapeutic uses, and pharmaceutical compositions that include these novel compounds.
Career Highlights
Mats Nagard is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing groundbreaking therapies that address various medical needs.
Collaborations
Mats has collaborated with esteemed colleagues, including Louise G. Edwards and Andreas Christer Wallberg, contributing to the advancement of pharmaceutical research and development.
Conclusion
Mats Nagard's innovative work in the field of pharmaceuticals exemplifies the impact of dedicated inventors on healthcare advancements. His contributions continue to influence therapeutic developments and improve patient outcomes.